Helfer, Bartosz

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Ferrari, A. J., Santomauro, D. F., Aali, A., Abate, Y. H., Abbafati, C., Abbastabar, H., Abd ElHafeez, S., Abdelmasseh, M., Abd-Elsalam, S., Abdollahi, A., et al. (2024) · The Lancet

Global Health and EpidemiologyInsurance, Mortality, Demography, Risk Management

Cited by 5,112

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Naghavi, M., Ong, K. L., Aali, A., Ababneh, H. S., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasian, M., Abbasi-Kangevari, M., Abbastabar, H., et al. (2024) · The Lancet

Insurance, Mortality, Demography, Risk ManagementGlobal Health and Epidemiology

Cited by 2,889

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021

Brauer, M., Roth, G. A., Aravkin, A. Y., Zheng, P., Abate, K. H., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., et al. (2024) · The Lancet

Cardiovascular Health and Risk FactorsGlobal Public Health Policies and Epidemiology

Cited by 2,884

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Schumacher, A. E., Kyu, H. H., Aali, A., Abbafati, C., Abbas, J., Abbasgholizadeh, R., Abbasi, M. A., Abbasian, M., Abd ElHafeez, S., Abdelmasseh, M., et al. (2024) · The Lancet

Insurance, Mortality, Demography, Risk ManagementCOVID-19 epidemiological studies

Cited by 1,045

Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Bhattacharjee, N. V., Schumacher, A. E., Aali, A., Abate, Y. H., Abbasgholizadeh, R., Abbasian, M., Abbasi-Kangevari, M., Abbastabar, H., Abd ElHafeez, S., Abd-Elsalam, S., et al. (2024) · The Lancet

Insurance, Mortality, Demography, Risk ManagementDemographic Trends and Gender Preferences

Cited by 629

Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors

Leucht, S., Leucht, C., Huhn, M., Chaimani, A., Mavridis, D., Helfer, B., Samara, M., Rabaioli, M., Bächer, S., Cipriani, A., et al. (2017) · American Journal of Psychiatry

Schizophrenia research and treatmentMeta-analysis and systematic reviews

Cited by 542

The global epidemiology and health burden of the autism spectrum: findings from the Global Burden of Disease Study 2021.

Santomauro, D. F., Erskine, H. E., Mantilla Herrera, A. M., Miller, P. A., Shadid, J., Hagins, H., Addo, I. Y., Adnani, Q. E. S., Ahinkorah, B. O., Ahmed, A., et al. (2025) · The Lancet Psychiatry

Autism Spectrum Disorder ResearchDown syndrome and intellectual disability research

Cited by 223

Carbamazepine for schizophrenia

Leucht, S., Helfer, B., Dold, M., Kissling, W., & McGrath, J. (2014) · Cochrane Database of Systematic Reviews

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 82

The effects of emotional lability, mind wandering and sleep quality on ADHD symptom severity in adults with ADHD

Helfer, B., Cooper, R. E., Bozhilova, N., Maltezos, S., Kuntsi, J., & Asherson, P. (2019) · European Psychiatry

Attention Deficit Hyperactivity DisorderMind wandering and attention

Cited by 32